Skip to main content
. Author manuscript; available in PMC: 2014 Jan 3.
Published in final edited form as: Surgery. 2012 Feb 4;151(6):10.1016/j.surg.2011.12.025. doi: 10.1016/j.surg.2011.12.025

Table 4.

Prognostic factors for overall survival after hepatic resection for HNEM (n=51)

Predictor of overall survival n (%) 5-year survival (%) Univariate analysis P value Multivariate Analysis
P value HR (95% CI)
Primary tumor type .75
 Adrenal 26 (51) 52
 Thyroidal 11 (22) 67
 Gonadal 14 (27) 66
Regional lymph nodes for primary tumor .85
 Positive 22 (43) 69
 Negative 29 (57) 49
Timing of detection of HNEM .17
 Synchronous 19 (37) 57
 Metachronous 32 (63) 62
Interval between primary tumor resection and diagnosis of HNEM .017 .037 5.33 (1.11–25.71)
 ≤ 12 months 28 (55) 42
 > 12 months 23 (45) 82
Number of liver metastases .97
 > 3 14 (27) 60
 ≤ 3 37 (73) 56
Maximum size of liver metastases .19
 ≥ 5 cm 25 (49) 46
 < 5 cm 26 (51) 76
Extrahepatic disease 0.68
 Present 26 (51) 60
 Absent 25 (49) 58
Two or more sites of extrahepatic disease .009 .028 4.80 (1.18–19.50)
 Present 7 (14) 0
 Absent 44 (86) 65
Major postoperative complication .13
 Present 7 (14) 33
 Absent 44 (86) 62
Preoperative systemic therapy for liver metastases .74
 Yes 24 (47) 52
 No 27 (53) 61
Postoperative systemic therapy for liver metastases .17
 Yes 17 (33) 52
 No 34 (67) 63
Extent of hepatectomy .06 NS
 Major 32 (63) 44
 Minor 19 (37) 93
Histological grade of primary tumor .3
 Low or intermediate 19 (37) 52
 High 19 (37) 50
Surgical margins for primary tumor .75
 Positive 9 (18) 58
 Negative 42 (82) 59
Surgical margins for liver metastases .21
 Positive 7 (14) 80
 Negative 44 (86) 53
Associated resection .13
 Yes 19 (37) 78
 No 32 (63) 43
Need for transfusions .58
 Yes 19 (37) 65
 No 32 (63) 54

Abbreviations: CI, confidence interval; HR, hazard ratio; NS, Not significant; HNEM, Hepatic nondigestive endocrine metastases.

Cox regression multivariate analysis included all variables with P less than .1 in univariate analysis.